Cabardo, Skyler Finn P.

HRN: 28-53-95  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2026
AMPICILLIN 1GM (VIAL)
02/24/2026
03/03/2026
IV
165mg
Q12H
T/C Neonatal Pneumonia
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: